Mayne Pharma, Inc. | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Mayne Pharma, Inc.

Sort by

Viewing results 1‒25 of 1450

WPP PLC
Ogilvy forms health influencer unit to target ‘new frontier’ in marketing
...Influencers affiliated with Ogilvy will need to clearly say when they are being paid by a pharma company....
April 23, 2024
News in-depthPfizer Inc
Covid vaccine winners suffer reversal of fortune
...The New York-based pharma group has acquired four companies — Arena, ReViral, Biohaven and Global Blood Therapeutics — that it expects will contribute about $10bn in revenues in 2030....
October 3, 2023
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
LexPfizer Inc
Pfizer: pharma group needs weight loss drug to secure post-Covid future Premium content
Company would have been better off following Roche’s route to market for anti-obesity treatment
December 13, 2023
News in-depthCovid-19 vaccines
Covid vaccine makers to clash in London over mRNA patent dispute
...Clarifying which companies are responsible for innovations will be “even more important” as pharma companies explore uses for mRNA in cancer, autoimmune diseases and other viruses, said Anna Wolters-Höhne...
April 22, 2024
Lex PopuliPersonal Finance
Stock splits: slicing the burrito
...Biotech business Redx Pharma this week blamed low liquidity on London’s junior market for its decision to delist its shares from Aim and re-register as a private company....
April 5, 2024
News in-depthWeight Watchers International Inc
WeightWatchers faces an era when weight loss comes in a syringe
...But some investors believe selling discipline against a shot is a losing game when big pharma companies are competing to meet the demands of the one in eight people worldwide who are classed as obese....
April 9, 2024
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
LexMergers & Acquisitions
Pharma: M&A strategy gets dose of bitter medicine Premium content
...The antitrust challenge may force big pharma groups to rethink “pure play” business models. The Lex team is interested in hearing more from readers. Is the FTC right to challenge pharma deals?...
June 12, 2023
Drugs research
Roche agrees $7.1bn deal for Telavant to boost drug pipeline
Swiss pharma group acquires rights to develop and manufacture bowel disease treatment
October 23, 2023
UnhedgedRobert Armstrong
Where increasing returns come from Premium content
...The first three sources are not the exclusive realm of knowledge industries such as tech or pharma....
February 5, 2024
Pharmaceuticals sector
Use of horseshoe crabs’ blue blood puts pharma groups under scrutiny
...But pressure is mounting on pharma companies to switch to synthetic substances as populations decline for horseshoe crabs and seabirds that eat the creatures’ eggs....
August 22, 2023
Amgen Inc
Amgen resolves US regulator’s challenge to $28bn Horizon deal
...Horizon had also attracted interest from French drugmaker Sanofi and US pharma group Johnson & Johnson....
September 1, 2023
US politics & policy
US targets 10 drugs for pricing negotiations in crackdown on costs
...Some pharma companies disputed the annual cost figures published by the health department....
August 29, 2023
LexMergers & Acquisitions
This Japanese buyer is paying up to find a US home for growth Premium content
...A shrinking domestic market is forcing Japan Inc to look for growth overseas. Ultra-low interest rates back home have further whetted the appetite for deals....
January 18, 2024
Merck & Co Inc
Merck to open £1bn London research centre with plea for government support of industry
...Merck’s research chief has called on the UK government to make the country more welcoming to pharma companies, ahead of the US-based drugmaker breaking ground on a £1bn research centre in London next week...
October 15, 2023
LexHealth
Amgen/FTC: deal bar ignores realities of pharma food chain Premium content
...Big Pharma has always bought out small drug developers to restock its pipelines. Some emerging health science companies aspire to be the next Amgen, which has a market capitalisation of $120bn....
May 17, 2023
FT Live
Due Diligence Live
Where leaders in investment and finance meet
Tuesday, 8 OctoberLondon, UK
Mergers & Acquisitions
M&A crackdown a ‘disaster’ for pharma sector, Pfizer executive warns
...Pao, speaking at the Financial Times US Pharma and Biotech Summit in New York, said he was confident the FTC would approve the Seagen deal....
May 17, 2023
Amgen Inc
FTC warns of ‘rampant’ pharma consolidation as it targets $28bn Amgen deal
US regulator sues to block takeover of biotech group Horizon Therapeutics
May 16, 2023
Coronavirus treatment
Covid antivirals lose spark as regulatory scrutiny increases
...Regulators have taken notice after a study sparked fresh doubts over the usefulness of a Covid drug made by US pharma group Merck, raising questions about the costly procurement of antivirals during the...
October 9, 2023
LexMerck & Co Inc
Merck/Prometheus: Big Pharma must swallow bigger premiums Premium content
...In a quieter deal environment, this deal underscores that Big Pharma has the means to make big bets....
April 17, 2023
InterviewJapanese business & finance
Japanese pharma boss rules out China exit after executive’s arrest
Astellas CEO says company will diversify supply chains in first comments since employee’s detention
April 9, 2023
Unhedged
Bank stocks’ problem isn’t just rates Premium content
...If you have the long pharma/short junk food pair trade on, email us: robert.armstrong@ft.com and ethan.wu@ft.com....
October 6, 2023
LexJohnson & Johnson Co Inc
Johnson & Johnson: second talc bankruptcy dismissal hits share price Premium content
...Late on Friday, a New Jersey bankruptcy court ruled that the big pharma company could not pursue a bankruptcy deal with tens of thousands of consumers who claim its talc powder caused serious illness....
July 31, 2023
ReviewTelevision
Painkiller is a surprisingly watchable drama about the opioid crisis
...OxyContin, a highly addictive drug, was promoted by Purdue Pharma as a non-addictive painkiller in the United States with unimaginably tragic consequences....
August 11, 2023
Pharmaceuticals sector
Big Pharma fights patent disclosure demand from investors
...Big pharma defends their patent strategies, arguing that intellectual property protection is required to justify continuing investment in existing drugs....
February 26, 2023
Amgen Inc
Regeneron boss backs attempt to block $28bn Amgen acquisition
...“I’m glad the FTC is looking at this,” Schleifer told the Financial Times US pharma and biotech summit in New York....
May 17, 2023

Previous pagePage 1 of 58Next page